Bone Solutions, Inc. ("BSI") a privately-owned, Dallas, TX, orthobiologics technology corporation uses its proprietary magnesium compounds to offer the medical industry on FDA approval a novel solution that will be powerful yet easy for surgeons to use in multiple orthopedic/oral applications. BSI believes its new products will result in increased success rates in a multitude of orthopedic related surgical applications.

We invite you to explore our site and learn more about our platform patented technology, with multiple additional patents pending, to see where it can have application to alternative ortho-oral markets that we estimate in potential size of more than $600 Million.

Our starting product, on FDA approval, is OsteoCrete™ Bone Void Filler, an injectable, moldable and biocompatible biologic product able to be fully bioabsorbable within an improved time frame for bone healing, providing bonding and mechanical support to bone on bone healing, tendon in bone repairs, and implants to bone.

OsteoCrete for Human Uses

BSI expects to complete its first of several 510(k) FDA approvals for a series of products, starting in 2008, with OsteoCrete™ Bone Void Filler. As a Bone Graft, and following FDA approval, the trauma market is where OsteoCrete™ Bone Void Filler will be targeted, including extremities, podiatry, and providing stabilization of femur and tibia fractures and other applications.

Separate 510 (k') applications are being planned following FDA protocol research for maxillofacial/cranial application, dental implants, a bone cement, an anchor, and dental cement.  For example, new products, following FDA approval, are expected to have the unique application of stabilizing and augmenting the invasive metallic fixation devices that tend to loosen in cementless hip, knee and shoulder surgeries, even extending to extremities and facial bone augmentation.   The Company is also applying for CE Mark Certification.  Bone Solutions believes its features are beyond the capabilities of any known bone filler or bone cement deployed globally today, opening up new, lower cost, surgical options for potentially many markets, on separate FDA approvals, for shoulder, knee, extremities, maxiollofacial/cranial and other surgeries.

Learn More about Osteocrete Technology